+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Veterinary Anti-Infectives Market by Species Type, by Drug Class, by Mode of Administration and End-users: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

  • ID: 4853067
  • Report
  • Region: Global
  • 110 pages
  • Zion Market Research
1 of 2

The report covers forecast and analysis for the veterinary anti-infectives market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the veterinary anti-infectives market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the veterinary anti-infectives market on a global level.

In order to give the users of this report a comprehensive view of the veterinary anti-infectives market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein species type segment, drug class segment and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

The study provides a decisive view on the veterinary anti-infectives market by segmenting the market based on species type, drug class, mode of administration, end-user and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2016 to 2022. Based on species type the market is segmented into livestock and companion animals. Based on drug class the market is segmented into antimicrobial agents, antiviral agents, antifungal agents and antiparasitic agents. On the basis of mode of administration, the market is segmented into oral, parenteral and topical. Key end-users covered under this study include veterinary hospitals, veterinary clinics, pharmacies and others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East & Africa with its further bifurcation into major countries including the U.S., Canada, Rest of North America, Germany, U.K., France, Italy, Spain, Russia, Rest of Europe, China, Japan, India, Australia, Rest of Asia Pacific, Brazil, Mexico, Argentina, Rest of Latin America, Saudi Arabia, UAE, Qatar, South Africa and Rest of Middle East and Africa. This segmentation includes demand for veterinary anti-infectives based on individual species type, drug class, mode of administration and end-users in all the regions and countries.

The report also includes detailed profiles of end players such as Bayer AG, Dechra Pharmaceuticals Ltd., Neogen Corporation, Phibro Animal Health Corporation, Vetoquinol S.A., Intas Pharmaceuticals, Inc., Ceva Santé Animale, Zydus Animal Health Limited, Cipla Limited, Heska Corporation, Virbac S.A., Zoetis, Inc., and Elanco Animal Health (Eli Lilly and Company).

This report segments the global veterinary anti-infectives market as follows:

Global Veterinary Anti-Infectives Market: Species Type Segment Analysis

  • Livestock
  • Companion

Global Veterinary Anti-Infectives Market: Drug Class Segment Analysis

  • Antimicrobial Agents
  • Antiviral Agents
  • Antifungal Agents
  • Antiparasitic Agents

Global Veterinary Anti-Infectives Market: Mode of Administration Segment Analysis

  • Oral
  • Parenteral
  • Topical

Global Veterinary Anti-Infectives Market: End-user Segment Analysis

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies
  • Others

Global Veterinary Anti-Infectives Market: Regional Segment Analysis

  • North America
  • U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Middle East and Africa
Note: Product cover images may vary from those shown
2 of 2
  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global veterinary anti-infectives market, 2016 – 2022 (USD Million)
    • 2.2. Global veterinary anti-Infectives market: Snapshot
  • Chapter 3. Veterinary Anti-Infectives Market– Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global veterinary anti-infectives market drivers: Impact analysis
      • 3.2.2. Increase in pet ownership
      • 3.2.3. Increase in zoonotic and foodborne diseases
      • 3.2.4. Improved nutrition
      • 3.2.5. Greater livestock production rates
    • 3.3. Market Restraints
      • 3.3.1. Global veterinary anti-infectives market restraints: Impact analysis
      • 3.3.2. Increasing raw material cost
      • 3.3.3. Stringent regulatory framework
      • 3.3.4. Scarcity of arable land and water
    • 3.4. Opportunities
      • 3.4.1. Biologics and specialty care offer huge opportunities
    • 3.5. Porter’s five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by species type segment
      • 3.6.2. Market attractiveness analysis, by drug class segment
      • 3.6.3. Market attractiveness analysis, by mode of administration segment
      • 3.6.4. Market attractiveness analysis, by end-user segment
      • 3.6.5. Market attractiveness analysis, by regional segment
  • Chapter 4. Global Veterinary Anti-Infectives Market– Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global veterinary anti-infectives market: company market share, 2016
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Species Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
    • 4.3. Price Trend Analysis
  • Chapter 5. Global Veterinary Anti-Infectives Market– Species Type Segment Analysis
    • 5.1. Global veterinary anti-infectives market: species type overview
      • 5.1.1. Global veterinary anti-infectives market revenue share, by species type, 2016 and 2022
    • 5.2. Livestock
      • 5.2.1. Global veterinary anti-infectives market for livestock market, 2016 – 2022 (USD Million)
    • 5.3. Companion
      • 5.3.1. Global veterinary anti-infectives market for companion market, 2016 – 2022 (USD Million)
  • Chapter 6. Global Veterinary Anti-Infectives Market– Drug Class Segment Analysis
    • 6.1. Global veterinary anti-infectives market: drug class overview
      • 6.1.1. Global veterinary anti-infectives market revenue share, by drug class, 2016 and 2022
    • 6.2. Antimicrobial Agents
      • 6.2.1. Global veterinary anti-infectives market for antimicrobial agents market, 2016 – 2022 (USD Million)
    • 6.3. Antiviral Agents
      • 6.3.1. Global veterinary anti-infectives market for antiviral agents market, 2016 – 2022 (USD Million)
    • 6.4. Antifungal Agents
      • 6.4.1. Global veterinary anti-infectives market for antifungal agents market, 2016 – 2022 (USD Million)
    • 6.5. Antiparasitic Agents
      • 6.5.1. Global veterinary anti-infectives market for antiparasitic agents market, 2016 – 2022 (USD Million)
  • Chapter 7. Global Veterinary Anti-Infectives Market– Mode of Administration Segment Analysis
    • 7.1. Global veterinary anti-infectives market: mode of administration overview
      • 7.1.1. Global veterinary anti-infectives market revenue share, by mode of administration class, 2016 and 2022
    • 7.2. Oral
      • 7.2.1. Global veterinary anti-infectives market for oral market, 2016 – 2022 (USD Million)
    • 7.3. Parenteral
      • 7.3.1. Global veterinary anti-infectives market for parenteral market, 2016 – 2022 (USD Million)
    • 7.4. Topical
      • 7.4.1. Global veterinary anti-infectives market for topical market, 2016 – 2022 (USD Million)
  • Chapter 8. Global Veterinary Anti-Infectives market– End-user Segment Analysis
    • 8.1. Global veterinary anti-infectives market: end-user overview
      • 8.1.1. Global veterinary anti-infectives market revenue share, by end-user, 2016 and 2022
    • 8.2. Veterinary Hospitals
      • 8.2.1. Global veterinary anti-infectives market for veterinary hospitals 2016 – 2022 (USD Million)
    • 8.3. Veterinary Clinics
      • 8.3.1. Global veterinary anti-infectives market for veterinary clinics, 2016 – 2022 (USD Million)
    • 8.4. Pharmacies
      • 8.4.1. Global veterinary anti-infectives market for pharmacies, 2016 – 2022 (USD Million)
    • 8.5. Others
      • 8.5.1. Global veterinary anti-infectives market for others end-users, 2016 – 2022 (USD Million)
  • Chapter 9. Global Veterinary Anti-Infectives Market– Regional Segment Analysis
    • 9.1. Global veterinary anti-infectives market: regional overview
      • 9.1.1. Global veterinary anti-infectives market revenue share, by region, 2016 and 2022
    • 9.2. North America
      • 9.2.1. North America veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
      • 9.2.2. North America veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
      • 9.2.3. North America veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
      • 9.2.4. North America veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.2.5. U.S.
        • 9.2.5.1. U.S. veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.2.5.2. U.S. veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
        • 9.2.5.3. U.S. veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
        • 9.2.5.4. U.S. veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.2.6. Canada
        • 9.2.6.1. Canada veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.2.6.2. Canada veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.2.6.3. Canada veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.2.6.4. Canada veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.2.7. Rest of North America
        • 9.2.7.1. Rest of North America veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.2.7.2. Rest of North America veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.2.7.3. Rest of North America veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.2.7.4. Rest of North America veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
    • 9.3. Europe
      • 9.3.1. Europe veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
      • 9.3.2. Europe veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
      • 9.3.3. Europe veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
      • 9.3.4. Europe veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.3.5. Germany
        • 9.3.5.1. Germany veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.3.5.2. Germany veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
        • 9.3.5.3. Germany veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
        • 9.3.5.4. Germany veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.3.6. U.K.
        • 9.3.6.1. U.K. veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.3.6.2. U.K. veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
        • 9.3.6.3. U.K. veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
        • 9.3.6.4. U.K. veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.3.7. France
        • 9.3.7.1. France veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.3.7.2. France veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
        • 9.3.7.3. France veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
        • 9.3.7.4. France veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.3.8. Italy
        • 9.3.8.1. Italy veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.3.8.2. Italy veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
        • 9.3.8.3. Italy veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
        • 9.3.8.4. Italy veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.3.9. Spain
        • 9.3.9.1. Spain veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.3.9.2. Spain veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
        • 9.3.9.3. Spain veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
        • 9.3.9.4. Spain veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.3.10. Russia
        • 9.3.10.1. Russia veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.3.10.2. Russia veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
        • 9.3.10.3. Russia veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
        • 9.3.10.4. Russia veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.3.11. Rest of Europe
        • 9.3.11.1. Rest of Europe veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.3.11.2. Rest of Europe veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
        • 9.3.11.3. Rest of Europe veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
        • 9.3.11.4. Rest of Europe veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
    • 9.4. Asia Pacific
      • 9.4.1. Asia Pacific veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
      • 9.4.2. Asia Pacific veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
      • 9.4.3. Asia Pacific veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
      • 9.4.4. Asia Pacific veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.4.5. China
        • 9.4.5.1. China veterinary anti-infectives market revenue, by species type, 2016 – 2022(USD Million)
        • 9.4.5.2. China veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
        • 9.4.5.3. China veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
        • 9.4.5.4. China veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.4.6. Japan
        • 9.4.6.1. Japan veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.4.6.2. Japan veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
        • 9.4.6.3. Japan veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
        • 9.4.6.4. Japan veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.4.7. India
        • 9.4.7.1. India veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.4.7.2. India veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
        • 9.4.7.3. India veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
        • 9.4.7.4. India veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.4.8. Australia
        • 9.4.8.1. Australia veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.4.8.2. Australia veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
        • 9.4.8.3. Australia veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
        • 9.4.8.4. Australia veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.4.9. Rest of Asia Pacific
        • 9.4.9.1. Rest of Asia Pacific veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.4.9.2. Rest of Asia Pacific veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
        • 9.4.9.3. Rest of Asia Pacific veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
        • 9.4.9.4. Rest of Asia Pacific veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
    • 9.5. Latin America
      • 9.5.1. Latin America veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
      • 9.5.2. Latin America veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
      • 9.5.3. Latin America veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
      • 9.5.4. Latin America veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.5.5. Brazil
        • 9.5.5.1. Brazil veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.5.5.2. Brazil veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
        • 9.5.5.3. Brazil veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
        • 9.5.5.4. Brazil veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.5.6. Mexico
        • 9.5.6.1. Mexico veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.5.6.2. Mexico veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
        • 9.5.6.3. Mexico veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
        • 9.5.6.4. Mexico veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.5.7. Argentina
        • 9.5.7.1. Argentina veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.5.7.2. Argentina veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
        • 9.5.7.3. Argentina veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
        • 9.5.7.4. Argentina veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.5.8. Rest of Latin America
        • 9.5.8.1. Rest of Latin America veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.5.8.2. Rest of Latin America veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
        • 9.5.8.3. Rest of Latin America veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
        • 9.5.8.4. Rest of Latin America veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
    • 9.6. Middle East and Africa
      • 9.6.1. Middle East and Africa veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
      • 9.6.2. Middle East and Africa veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
      • 9.6.3. Middle East and Africa veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
      • 9.6.4. Middle East and Africa veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.6.5. Saudi Arabia
        • 9.6.5.1. Saudi Arabia veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.6.5.2. Saudi Arabia veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
        • 9.6.5.3. Saudi Arabia veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
        • 9.6.5.4. Saudi Arabia veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.6.6. UAE
        • 9.6.6.1. UAE veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.6.6.2. UAE veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
        • 9.6.6.3. UAE veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
        • 9.6.6.4. UAE veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.6.7. Qatar
        • 9.6.7.1. Qatar veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.6.7.2. Qatar veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
        • 9.6.7.3. Qatar veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
        • 9.6.7.4. Qatar veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.6.8. South Africa
        • 9.6.8.1. South Africa veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.6.8.2. South Africa veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
        • 9.6.8.3. South Africa veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
        • 9.6.8.4. South Africa veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
      • 9.6.9. Rest of Middle East and Africa
        • 9.6.9.1. Rest of Middle East and Africa veterinary anti-infectives market revenue, by species type, 2016 – 2022 (USD Million)
        • 9.6.9.2. Rest of Middle East and Africa veterinary anti-infectives market revenue, by drug class, 2016 – 2022 (USD Million)
        • 9.6.9.3. Rest of Middle East and Africa veterinary anti-infectives market revenue, by mode of administration, 2016 – 2022 (USD Million)
        • 9.6.9.4. Rest of Middle East and Africa veterinary anti-infectives market revenue, by end-user, 2016 – 2022 (USD Million)
  • Chapter 10. Company Profile
    • 10.1. Bayer AG
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Species portfolio
      • 10.1.4. Business strategy
      • 10.1.5. Recent developments
    • 10.2. Dechra Pharmaceuticals Ltd.
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Species portfolio
      • 10.2.4. Business strategy
      • 10.2.5. Recent developments
    • 10.3. Neogen Corporation
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Species portfolio
      • 10.3.4. Business strategy
      • 10.3.5. Recent developments
    • 10.4. Phibro Animal Health Corporation
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Species portfolio
      • 10.4.4. Business strategy
      • 10.4.5. Recent developments
    • 10.5. Vetoquinol S.A.
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Species portfolio
      • 10.5.4. Business strategy
      • 10.5.5. Recent developments
    • 10.6. Intas Pharmaceuticals, Inc.
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Species portfolio
      • 10.6.4. Business strategy
      • 10.6.5. Recent developments
    • 10.7. Ceva Santé Animale
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 10.7.3. Species portfolio
      • 10.7.4. Business strategy
      • 10.7.5. Recent developments
    • 10.8. Zydus Animal Health Limited
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Species portfolio
      • 10.8.4. Business strategy
      • 10.8.5. Recent developments
    • 10.9. Heska Corporation
      • 10.9.1. Overview
      • 10.9.2. Financials
      • 10.9.3. Species portfolio
      • 10.9.4. Business strategy
      • 10.9.5. Recent developments
    • 10.10. Cipla Limited
      • 10.10.1. Overview
      • 10.10.2. Financials
      • 10.10.3. Species portfolio
      • 10.10.4. Business strategy
      • 10.10.5. Recent developments
    • 10.11. Virbac S.A.
      • 10.11.1. Overview
      • 10.11.2. Financials
      • 10.11.3. Species portfolio
      • 10.11.4. Business strategy
      • 10.11.5. Recent developments
    • 10.12. Zoetis, Inc.
      • 10.12.1. Overview
      • 10.12.2. Financials
      • 10.12.3. Species portfolio
      • 10.12.4. Business strategy
      • 10.12.5. Recent developments
    • 10.13. Elanco Animal Health (Eli Lilly and Company)
      • 10.13.1. Overview
      • 10.13.2. Financials
      • 10.13.3. Species portfolio
      • 10.13.4. Business strategy
      • 10.13.5. Recent developments
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll